BioNTech agrees to acquire former COVID vaccine rival CureVac-February 2024-www.financetom.com

BioNTech agrees to acquire former COVID vaccine rival CureVac

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BioNTech agrees to acquire former COVID vaccine rival CureVac

Jun 12, 2025 4:18 AM

June 12 (Reuters) - German biotech firm BioNTech

said on Thursday it agreed to acquire domestic peer

CureVac ( CVAC ) for about $1.25 billion worth of BioNTech

shares, eyeing a combination of the two former rivals in the

race to develop COVID-19 vaccines.

Previous page： Cohu Wins $100 Million Deal with European Electronics, Semiconductor Manufacturer Next page： Firm Capital Apartment REIT Providing Strategic Review Update Including Florida Property Sale and Early Redemption of Convertible Debenture

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cohu Wins $100 Million Deal with European Electronics, Semiconductor Manufacturer

May 22, 2024

05:16 PM EDT, 05/22/2024 (MT Newswires) -- Cohu ( COHU ) said Wednesday that a European electronics and semiconductor manufacturer selected the company's test and inspection automation systems. The deal represents about a $100 million revenue opportunity over the next five years, according to the company. Price: 31.25, Change: +0.35, Percent Change: +1.13 ...

Firm Capital Apartment REIT Providing Strategic Review Update Including Florida Property Sale and Early Redemption of Convertible Debenture

May 22, 2024

05:16 PM EDT, 05/22/2024 (MT Newswires) -- Firm Capital Apartment Real Estate Investment Trust (FCA-U.V, FCA-UN.V) after trade Wednesday reported it has completed the sale of one of its wholly-owned multi-family assets located in Florida for US$30.5 million. A statement noted the Florida property had a sales price in line with its IFRS value. Wednesday's statement noted net of associated...

Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing

May 22, 2024

05:17 PM EDT, 05/22/2024 (MT Newswires) -- Anthony Hunt, Chief Executive Officer, on May 21, 2024, sold 20,072 shares in Repligen ( RGEN ) for $3,377,283. Following the Form 4 filing with the SEC, Hunt has control over a total of 163,177 shares of the company, with 163,177 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/730272/000095017024063594/xslF345X03/ownership.xml ...

Molina Healthcare Expects Unit to Receive Contract From Wisconsin Department of Health Services

May 22, 2024

05:15 PM EDT, 05/22/2024 (MT Newswires) -- Molina Healthcare ( MOH ) said late Wednesday that the Wisconsin Department of Health Services intends to award a contract to its Wisconsin unit, with the go-live date expected to be Jan. 1, 2025. The contract to Molina Healthcare of Wisconsin is for services in its Geographic Service Region 5, the company said,...